The first drug capable of delaying the onset of type 1 diabetes, Teplizumab, is now accessible on the NHS in England and Wales, offering potential years without insulin treatment.
The first drug capable of delaying the onset of type 1 diabetes, Teplizumab, is now accessible on the NHS in England and Wales, offering potential years without insulin treatment.